当前位置：首页 JCRQ3 期刊介绍(非官网)

Cardiovascular Revascularization Medicine

SCIE

国际简称：CARDIOVASC REVASCULA 参考译名：心血管血运重建医学

CiteScore分区
Q2
JCR分区
Q3

基本信息：: ISSN：1553-8389; E-ISSN：1878-0938; 是否OA：未开放; 是否预警：否

出版信息：: 出版商：Elsevier; 出版语言：English; 研究方向：CARDIAC & CARDIOVASCULAR SYSTEMS

评价信息：: 影响因子：1.6; CiteScore指数：3.3; SJR指数：0.49; SNIP指数：0.6

发文数据：: Gold OA文章占比：11.27%; 研究类文章占比：90.72%; 年发文量：194

投稿咨询加急见刊

英文简介期刊介绍 CiteScore数据 JCR分区发文数据常见问题

英文简介Cardiovascular Revascularization Medicine期刊介绍

Cardiovascular Revascalization Medicine is an academic journal dedicated to the field of cardiovascular reconstruction medicine, aiming to provide a platform for cardiovascular disease experts, cardiovascular surgeons, interventional cardiologists, and other related medical professionals to exchange and share the latest research results, clinical experience, and technological innovations. The magazine covers various aspects of cardiovascular reconstruction medicine, including coronary artery disease, peripheral vascular disease, carotid artery disease, venous disease, etc. The article types are rich and diverse, including original research papers, review articles, case reports, technological advances, guidelines, and consensus, providing readers with the latest research trends, clinical practices, and technological developments in cardiovascular reconstruction medicine. The magazine is committed to promoting the development of cardiovascular reconstruction medicine, improving the diagnosis and treatment of cardiovascular diseases, encouraging innovative thinking, supporting interdisciplinary cooperation, and promoting scientific research and technological progress in the field of cardiovascular reconstruction medicine. By publishing high-quality research papers and review articles, this journal provides a platform for cardiovascular disease experts to understand the latest research results, master clinical skills, and improve diagnosis and treatment levels.

期刊简介Cardiovascular Revascularization Medicine期刊介绍

《Cardiovascular Revascularization Medicine》该刊近一年未被列入预警期刊名单，目前已被权威数据库SCIE收录，得到了广泛的认可。

该期刊投稿重要关注点：

预计审稿时间：
SCIE
非预警

Cite Score数据（2024年最新版）Cardiovascular Revascularization Medicine Cite Score数据

CiteScore：3.3
SJR：0.493
SNIP：0.597

学科类别	分区	排名	百分位
大类：Medicine 小类：Cardiology and Cardiovascular Medicine	Q2	188 / 387	51%

CiteScore 是由Elsevier(爱思唯尔)推出的另一种评价期刊影响力的文献计量指标。反映出一家期刊近期发表论文的年篇均引用次数。CiteScore以Scopus数据库中收集的引文为基础，针对的是前四年发表的论文的引文。CiteScore的意义在于，它可以为学术界提供一种新的、更全面、更客观地评价期刊影响力的方法，而不仅仅是通过影响因子(IF)这一单一指标来评价。

历年Cite Score趋势图

JCR分区Cardiovascular Revascularization Medicine JCR分区

2023-2024 年最新版

按JIF指标学科分区	收录子集	分区	排名	百分位
学科：CARDIAC & CARDIOVASCULAR SYSTEMS	ESCI	Q3	137 / 220	38%

按JCI指标学科分区	收录子集	分区	排名	百分位
学科：CARDIAC & CARDIOVASCULAR SYSTEMS	ESCI	Q3	120 / 220	45.68%

JCR分区的优势在于它可以帮助读者对学术文献质量进行评估。不同学科的文章引用量可能存在较大的差异，此时单独依靠影响因子(IF)评价期刊的质量可能是存在一定问题的。因此，JCR将期刊按照学科门类和影响因子分为不同的分区，这样读者可以根据自己的研究领域和需求选择合适的期刊。

历年影响因子趋势图

本刊中国学者近年发表论文

1、In-Hospital Heart Failure in Patients With Takotsubo Cardiomyopathy Due to Coronary Artery Disease: An Artificial Intelligence and Optical Coherence Tomography Study
Author: Kumar, Sant; Chu, Miao; Sans-Rosello, Jordi; Fernandez-Peregrina, Estefania; Kahsay, Yirga; Gonzalo, Nieves; Salazar, Carlos Hernando; Alfonso, Fernando; Tu, Shengxian; Garcia-Garcia, Hector M.

Journal: CARDIOVASCULAR REVASCULARIZATION MEDICINE. 2023; Vol. 47, Issue , pp. 40-45. DOI: 10.1016/j.carrev.2022.09.010